Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?
Stergios A. Pοlyzos, Jannis Kountouras, Christos S. Mantzoros
Metabolism (2019) Vol. 96, pp. iii-v
Closed Access | Times Cited: 19

Showing 19 citing articles:

Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Michael Doulberis, Simone Srivastava, Stergios A. Pοlyzos, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 933-933
Open Access | Times Cited: 67
Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration
Jannis Kountouras, Marina Boziki, Evangelos Kazakos, et al.
Neurochemistry International (2024) Vol. 175, pp. 105724-105724
Closed Access | Times Cited: 7
Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. Pοlyzos, et al.
Microorganisms (2021) Vol. 9, Iss. 11, pp. 2351-2351
Open Access | Times Cited: 32
Portal hypertension aggravates Helicobacter pylori induced liver injury in mice via activating pyroptosis pathway
Jianjun Hu, Lei Gao, Ewetse Paul Maswikiti, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Impact of Helicobacter pylori and metabolic syndrome-related mast cell activation on cardiovascular diseases
Michael Doulberis, Apostolis Papaefthymiou, Stergios A. Pοlyzos, et al.
Frontiers in Gastroenterology (2024) Vol. 3
Open Access | Times Cited: 2
Reconsidering the “protective” hypothesis of Helicobacter pylori infection in eosinophilic esophagitis
Michael Doulberis, Jannis Kountouras, Gerhard Rogler
Annals of the New York Academy of Sciences (2020) Vol. 1481, Iss. 1, pp. 59-71
Open Access | Times Cited: 18
The possible role of Helicobacter pylori in liver diseases
Mahnaz Mohammadi, Adeleh Attar, Maryam Mohammadbeigi, et al.
Archives of Microbiology (2023) Vol. 205, Iss. 8
Closed Access | Times Cited: 6
Impact of Helicobacter pylori‐linked metabolic syndrome on non‐alcoholic fatty liver disease and its connected atrial fibrillation risk
Jannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, et al.
Liver International (2020) Vol. 40, Iss. 8, pp. 2036-2037
Closed Access | Times Cited: 12
Prospective cohort study of Helicobacter pylori infection on the risk of nonalcoholic fatty liver disease
Changxi Chen, Sha Si, Juan Du, et al.
FACETS (2024) Vol. 9, pp. 1-8
Open Access | Times Cited: 1
Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents
Michael Doulberis, Stergios A. Pοlyzos, Apostolis Papaefthymiou, et al.
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 3, pp. 247-251
Open Access | Times Cited: 10
Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease
Theodor Baars, Robert K. Gieseler, Polykarpos Patsalis, et al.
Metabolism (2022) Vol. 130, pp. 155179-155179
Closed Access | Times Cited: 6
Association between Helicobacter pylori infection and non-alcoholic fatty liver disease for Asian and non-Asian population: A systematic review and meta-analysis
Zhiyuan Ma, Xiajing Chu, Xiang Yan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 6
Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders
Marina Boziki, Stergios A. Pοlyzos, Apostolis Papaefthymiou, et al.
Metabolism (2021) Vol. 118, pp. 154736-154736
Closed Access | Times Cited: 8
Update on the association between non‐alcoholic fatty liver disease andHelicobacter pyloriinfection
Michael Doulberis, Apostolis Papaefthymiou, David Srivastava, et al.
International Journal of Clinical Practice (2020) Vol. 75, Iss. 4
Closed Access | Times Cited: 8
Seroprevalence of Helicobacter pylori and its association with metabolic syndrome in a rural community of Bangladesh
M. Masudur Rahman, Md. Golam Kibria, Nigar Sultana, et al.
JGH Open (2020) Vol. 5, Iss. 1, pp. 64-72
Open Access | Times Cited: 8
Diagnostic gene biomarkers for predicting immune infiltration in endometriosis
Chengmao Xie, Chang Lu, Liu Y, et al.
BMC Women s Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Is the Occurrence or Reversal of Nonalcoholic Fatty Liver Disease Associated with Long-Term Helicobacter pylori Infection among Chinese Adults? A Cohort Study
Zhao Xia-xia, Rui-Ling Wang, Ming‐Hao Liu, et al.
Gastroenterology Research and Practice (2021) Vol. 2021, pp. 1-8
Open Access | Times Cited: 4
Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut–Brain Axis and Helicobacter pylori Infection
Marina Boziki, Paschalis Theotokis, Evangelia Kesidou, et al.
Neurology International (2024) Vol. 16, Iss. 6, pp. 1750-1778
Open Access
Nonalcoholic Fatty Liver Disease and Helicobacter pylori Infection: Is it Time to Address this Potential Relationship?
Stergios A. Pοlyzos, Jannis Kountouras
Current Vascular Pharmacology (2023) Vol. 21, Iss. 2, pp. 78-80
Closed Access
Page 1

Scroll to top